ADVB Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Advanced Biomed Inc (ADVB.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Advanced Biomed Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

ADVB News & Events

Events Timeline

No data

News

7.5

2025-12-30Globenewswire

Advanced Biomed Sells Hong Kong Subsidiary for $23,000

8.5

2025-12-30Newsfilter

Advanced Biomed Sells Hong Kong Subsidiary for $23,000

8.5

2025-09-29TipRanks

2025 IPO Successes and Failures: Figma, Bullish, and Klarna Drive $31 Billion Revival

People Also Watch

Frequently Asked Questions

What is Advanced Biomed Inc (ADVB) stock price today?

The current price of ADVB is 0.3589 USD — it has increased 1.13 % in the last trading day.

What is Advanced Biomed Inc (ADVB)'s business?

Advanced Biomed Inc. is a holding company that operates, through its subsidiary, Advanced Biomed Inc. (Taiwan). The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. The Company has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and enables localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology.

What is the price predicton of ADVB Stock?

Wall Street analysts forecast ADVB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ADVB is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Advanced Biomed Inc (ADVB)'s revenue for the last quarter?

Advanced Biomed Inc revenue for the last quarter amounts to -523.91K USD, increased 0.75 % YoY.

What is Advanced Biomed Inc (ADVB)'s earnings per share (EPS) for the last quarter?

Advanced Biomed Inc. EPS for the last quarter amounts to -612113.00 USD, increased 1132.66 % YoY.

What changes have occurred in the market's expectations for Advanced Biomed Inc (ADVB)'s fundamentals?

The market is revising No Change the revenue expectations for ADVB for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -26.77%.

How many employees does Advanced Biomed Inc (ADVB). have?

Advanced Biomed Inc (ADVB) has 31 emplpoyees as of January 10 2026.

What is Advanced Biomed Inc (ADVB) market cap?

Today ADVB has the market capitalization of 7.77M USD.